低剂量普罗波作为单独的镇静剂在术后呼吸肝移植接受者:一个初步的观察性研究
Rishabh Jaju1, Kelika Prakash2, M K Arora3
1Department of Anaesthesia and Critical Care, All India Institute of Medical Sciences, Deoghar, Jharkhand, India.
Journal of anaesthesiology, clinical pharmacology
|May 30, 2023
概括
肝移植后的患者需要较低剂量的 пропофол进行镇静. 这项研究发现,活体供体肝移植接受者需要比标准剂量更少的普罗波来进行有效的镇静.
科学领域:
- 麻醉学 麻醉学
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 肝移植 (LT) 改变了药物代谢,原因是肝脏质量,血流,蛋白质水平和再生的变化.
- 标准的普罗波福尔剂量 (1.5-4.5 mg.kg−1.h−1) 可能对LT后的患者来说不是最佳的.
- 改变的药理动力学需要评估在这个人群中对普罗波的需求.
研究的目的:
- 评估选择性通风活供体肝移植 (LDLT) 接受者的镇静所需的普罗波福尔剂量.
- 为了比较实际的propofol剂量与用于镇静的常规剂量.
- 评估在LDLT后的ICU环境中调整的propofol剂量的安全性和有效性.
主要方法:
- 在LDLT后的ICU患者中,以1mg.kg-1.h-1开始的propofol输液.
- 剂量定位以保持双光谱指数 (BIS) 的60-80.
- 没有同时使用其他镇静剂 (阿片类药物,二类药物);监测普罗波福,诺拉德林和乳酸盐水平.
主要成果:
- 平均需要的普罗波福尔剂量为1.02 ± 0.26 mg.kg-1.h-1,明显低于标准剂量.
- 在ICU转移后的14小时内,诺拉丁上腺素被断奶.
- 在停止使用普罗波后大约2小时内发生了输出.
- 没有发现propofol剂量与乳酸,氨或移植与受体重量比率之间的相关性.
结论:
- 在LDLT接受者中,用于术后镇静的普罗波所需剂量范围低于常规剂量.
- 在LDLT后的手术后期,较低的普罗波福尔剂量可能足以用于镇静.
- 这一发现支持在肝移植接受者中进行个性化位的普罗波.
相关概念视频
Parenteral Anesthetics: Overview
163
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
163
General Anesthesia: Overview
249
Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
249
Stages of General Anesthesia
517
Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
517
Inhalational Anesthetics: Overview
362
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
362
Sedatives and Hypnotics Drugs: Miscellaneous Agents
205
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
205
Sedatives and Hypnotics: Overview
480
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
480


